Anders Boyd
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in ⓘ
- Hepatology 88
- Hepatitis C virus research 86
-
- HIV/AIDS Research and Interventions 74
- HIV/AIDS drug development and treatment 19
- Co-authors
- Karine Lacombe (62 shared papers)Pierre‐Marie Girard (46 shared papers)Fabien Zoulim (26 shared papers)Steven Collins (9 shared papers)Maria Prins (58 shared papers)Viviane Kovess–Masféty (13 shared papers)Udi Davidovich (34 shared papers)Guillaume Arlet (8 shared papers)
- Journals
- AIDS (18 papers)PLoS ONE (15 papers)Open Forum Infectious Diseases (9 papers)Antiviral Therapy (7 papers)Journal of Antimicrobial Chemotherapy (6 papers)
- Partner nations
- NetherlandsFranceUnited States
In The Last Decade
Anders Boyd
210 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 125
- Hepatology 1.0k
- Molecular Medicine 342
- Infectious Diseases 1.0k
- Epidemiology 1.7k
- Virology 205
Countries citing papers authored by Anders Boyd
This map shows the geographic impact of Anders Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Boyd more than expected).
Fields of papers citing papers by Anders Boyd
This network shows the impact of papers produced by Anders Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Boyd. The network helps show where Anders Boyd may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Boyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 229 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 212 | |
| 2 | 1999 | 162 | |
| 3 | 2008 | 133 | |
| 4 | 2019 | 103 | |
| 5 | 2021 | 102 | |
| 6 | 2011 | 91 | |
| 7 | 2016 | 84 | |
| 8 | 2010 | 83 | |
| 9 | 2015 | 74 | |
| 10 | 2012 | 73 | |
| 11 | 2014 | 61 | |
| 12 | 2015 | 58 | |
| 13 | 2014 | 57 | |
| 14 | 2015 | 57 | |
| 15 | 2006 | 55 | |
| 16 | 2000 | 54 | |
| 17 | 2012 | 54 | |
| 18 | 2020 | 48 | |
| 19 | 2022 | 47 | |
| 20 | 2017 | 46 |
About Anders Boyd
Anders Boyd is a scholar working on Hepatology, Infectious Diseases, Virology, Epidemiology and Applied Microbiology and Biotechnology, having authored 229 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (86 papers), Hepatitis B Virus Studies (78 papers), HIV/AIDS Research and Interventions (74 papers), Liver Disease Diagnosis and Treatment (48 papers), HIV, Drug Use, Sexual Risk (42 papers), HIV Research and Treatment (19 papers), HIV/AIDS drug development and treatment (19 papers) and Adolescent Sexual and Reproductive Health (16 papers). The work is most often cited by research in Hepatology (1.0k citations), Molecular Medicine (342 citations), Infectious Diseases (1.0k citations), Epidemiology (1.7k citations) and Virology (205 citations). Anders Boyd has collaborated with scholars based in Netherlands, France and United States. Frequent co-authors include Karine Lacombe, Pierre‐Marie Girard, Fabien Zoulim, Steven Collins, Maria Prins, Viviane Kovess–Masféty, Udi Davidovich, Guillaume Arlet, Joël Gozlan and Jordi Alonso. Their work appears in journals such as AIDS, PLoS ONE, Open Forum Infectious Diseases, Antiviral Therapy and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.